Thu, August 10, 2023

Derek Archila Maintained (ZNTL) at Buy with Decreased Target to $50 on, Aug 10th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-50-on-aug-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Derek Archila of Wells Fargo, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $51 to $50 on, Aug 10th, 2023.

Derek has made no other calls on ZNTL in the last 4 months.



There are 3 other peers that have a rating on ZNTL. Out of the 3 peers that are also analyzing ZNTL, 0 agree with Derek's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Derek


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $50 on, Wednesday, June 7th, 2023
  • Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $50 on, Friday, May 26th, 2023
  • Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $70 on, Friday, May 19th, 2023